Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Humacyte, Inc.
With
This is a Phase 3, prospective, multicenter, multinational, open-label, randomized, two-arm, comparative study. Subjects who sign informed consent would undergo study-specific screening assessments within 35 days from the day of informed consent. Participants who consented were randomized to the HAV treatment arm of one of the two commercially available comparators.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted